Global Biotech Summit 2026 to Convene Global Leaders in Abu Dhabi
The inaugural Global Biotech Summit will take place on June 10–11, 2026, at Beach Rotana, Abu Dhabi, bringing together international leaders from biotechnology, healthcare, research, and investment.
The two-day conference & exhibition is designed to provide a focused platform for dialogue, partnerships, and commercial opportunities across biotechnology, precision medicine, advanced therapeutics, and emerging health technologies. It aims to connect policymakers, researchers, industry executives, investors, and innovators to discuss practical pathways for advancing life sciences globally.
“The Global Biotechnology Summit is about turning research into real-world outcomes,” said a spokesperson for the organisers. “It brings together the people who can fund, regulate, develop, and scale innovation in a way that benefits patients and healthcare systems worldwide.”
Confirmed Speakers
The first group of confirmed speakers includes senior leaders from prominent healthcare and life sciences institutions:
- Dr. Asma Al Mannaei – Executive Director, Health Life Sciences Sector, Department of Health – Abu Dhabi
- Albarah El-Khani – Chief Operating Officer, M42 Health
- Yendry Ventura, MD – Chief Executive Officer, ADSCC
- Boyd Chongphaisal – Vice President & General Manager, Gulf, GSK
- Ayman El-Hussein – Managing Director, Siemens Healthineers, UAE
The programme will cover biotechnology development, artificial intelligence in healthcare, regulatory frameworks, translational research, and strategies for scaling innovation.
Event Highlights
The Summit is expected to host:
- 1,200+ senior professionals and decision-makers
- 75+ international speakers
- 50+ sponsors and exhibitors
- 300+ global and regional brands
- 50+ media and supporting partners
The agenda will feature keynote addresses, executive roundtables, panel discussions, startup presentations, investor meetings, and curated networking sessions.
A Business Platform for Global Collaboration
The Global Biotech Summit is structured as a B2B platform, facilitating collaboration between governments, multinational corporations, biotech startups, venture capital firms, research institutions, and healthcare providers.
Key focus areas include genomics, biomanufacturing, digital health systems, and advanced therapeutic development. The objective is to encourage investment, strengthen regulatory dialogue, and support commercial partnerships that can accelerate the delivery of new healthcare solutions.
Organised by Resolute Market Intelligence, Global Biotech Summit aims to establish Abu Dhabi as a strategic meeting point for the global biotechnology community.
Registration & Enquiries
Industry professionals, investors, and organisations interested in participating can submit enquiries via the official website: Submit Your Enquiry
